Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
none
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Incyte_Corporation
|
| https://www.w3.org/2000/01/rdf-schema#label |
INCB050465
|
| gptkbp:intendedUse |
oncology
|
| gptkbp:mechanismOfAction |
FGFR inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:FGFR3
gptkb:FGFR1 gptkb:FGFR4 gptkb:FGFR2 |
| gptkbp:bfsParent |
gptkb:parsaclisib
|
| gptkbp:bfsLayer |
6
|